SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-051615
Filing Date
2023-10-03
Accepted
2023-10-03 16:56:48
Documents
1
Period of Report
2023-10-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4054
  Complete submission text file 0000950170-23-051615.txt   5612
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Issuer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Ros Matthew (Reporting) CIK: 0001673802 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38443 | Film No.: 231304946